Daniel E Furst MD
Carl M Pearson Professor of Rheumatology
Univ of Cal at Los Angeles
1000 Veteran Ave Rm 32-59
Los Angeles Ca 90095-1670
Daniel E. Furst is Professor of Medicine at the University of California(emeritus), Los Angeles (UCLA), Medical Center, David Geffen School of Medicine, Department of Medicine, Division of Rheumatology. He is also Adjunct professor at the university of Washington, Seattle Washington and Research Professor at the University of Florence, Florence, Italy.
He has part time practices at the Arthritis Associates of Southern California and the Seattle Rhuematology Associates in Seattle Washington.
Dr. Furst received his MD from Johns Hopkins University, where he also completed his internship and residency. He completed two fellowships, one in Rheumatology at UCLA Medical Center, and a second in clinical pharmacology at the University of California, San Francisco Medical Center.
After serving as assistant professor of medicine/rheumatology at the UCLA Medical Center and associate professor of internal medicine/Rheumatology at the University of Iowa Carver College of Medicine, Dr. Furst became clinical professor in the Department of Medicine, Division of Rheumatology and Connective Tissue Research at the University of Medicine and Dentistry of New Jersey, and director of AI/P Clinical Research at Ciba Geigy Pharmaceuticals. He then moved to Seattle, where he was clinical professor of medicine at the University of Washington, then director of clinical research programs and director of the Arthritis Clinical Research Unit at the Virginia Mason Medical Center. He took up his position at UCLA in 2002 and became emeritus in 2015. At that time he took on his several other positions and practices, thus both enlarging his research and clinical practices.
He is on the national medical advisory board of the Scleroderma Foundation, the scientific advisory board of the Arthritis Foundation, and the board of directors for the foundation of the Collaboration of Research Rheumatologists of North America. He is on the editorial review board of numerous clinical pharmacology and rheumatic disease journals. He has written over 800 original articles/reviews/chapters and written or edited 14 books on rheumatic diseases.